You just read:

Recordati Rare Diseases Inc. Acquires North American Marketing Rights to CYSTADANE® (Betaine Anhydrous for Oral Solution)

News provided by

Recordati Rare Diseases Inc.

Apr 13, 2017, 08:00 ET